InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (13 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
13
T+90 hit rate
14%
T+90 mean return
-9.4%
Across 7 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the detailed record of transactions filed by BENEVICH ERIC, Directeur Commercial. Officer active across 1 company, notably Neurocrine Biosciences INC. Aggregated, 26 reports have been published. Breakdown: 0 buy · 13 sells. Total volume traded: €3.2m. History available since 16 August 2021. The latest transaction was disclosed on 28 November 2025 (Levée d'options). Regulator: SEC (Form 4). All data is free.
Declarations26 total
12,830 shares@ US$35.9922.5% of flowCommon StockSEC:0001643653-26-000005
12,830 shares@ US$35.990.0028% mcap22.5% of flowCommon StockSEC:0001643653-26-000005:0
5,970 shares@ US$151.73888.5% of flowCommon StockSEC:0001643653-25-000007:1
5,970 shares@ US$35.992.0% of flowCommon StockSEC:0001643653-25-000007:0
2,083 shares0Common StockSEC:0000914475-25-000057:0
1,860 shares0Common StockSEC:0000914475-25-000047:0
2,294 shares0Common StockSEC:0000914475-25-000021:0
7,231 shares@ US$81.496.0% of flowCommon StockSEC:0000914475-24-000111:0
5,479 shares@ US$79.024.3% of flowCommon StockSEC:0000914475-24-000096:0
53,143 shares@ US$43.2423.0% of flowCommon StockSEC:0000914475-24-000082:0
1,098 shares@ US$133.01491.5% of flowCommon StockSEC:0000914475-24-000068:0
1,280 shares@ US$142.11721.8% of flowCommon StockSEC:0000914475-24-000044:0
1,207 shares@ US$140.78441.7% of flowCommon StockSEC:0000914475-24-000023:0
1,600 shares@ US$107.39751.7% of flowCommon StockSEC:0001209191-23-047128:0
1,280 shares@ US$105.62561.4% of flowCommon StockSEC:0001209191-23-007907:0
1,207 shares@ US$109.95051.3% of flowCommon StockSEC:0001209191-23-006259:0
400 shares@ US$43.240.2% of flowCommon StockSEC:0001209191-23-002829:0
400 shares@ US$125.000.5% of flowCommon StockSEC:0001209191-23-002829:1
22,162 shares@ US$41.789.7% of flowCommon StockSEC:0001209191-22-059245:0
24,593 shares@ US$41.7811.1% of flowCommon StockSEC:0001209191-22-056437:0
400 shares@ US$41.780.2% of flowCommon StockSEC:0001209191-22-055817:0
4,960 shares@ US$110.82296.0% of flowCommon StockSEC:0001209191-22-054117:0
809 shares@ US$80.67870.0004% mcap3.2% of flowCommon StockSEC:0001209191-22-008204:0
809 shares@ US$80.67870.0004% mcap6.5% of flowCommon StockSEC:0001209191-22-008204
5,628 shares@ US$89.62244.6% of flowCommon StockSEC:0001209191-21-052337
25 of 26 declarations
About BENEVICH ERIC
Eric Benevich serves as Chief Commercial Officer at NEUROCRINE BIOSCIENCES INC. He is responsible for the company's commercial strategy and business development. Eric brings expertise in sales management and business strategy, enabling him to drive growth initiatives. His role is essential for achieving Neurocrine's performance objectives.
